NOVO Medi Sciences Pvt
Manufacturing · India · 309 Employees
View Company Info for Free
About
Headquarters
40-b/1 Shankar Smruti Sir Bhalchandra Rd Dadar ...Phone Number
+91 2243426100Website
www.novomedi.comRevenue
$6.7 MillionIndustry
Recent News & Media
No recent news or media
Who is NOVO Medi Sciences Pvt
Novo Medi is an leading Indian Pharmaceutical company in providing affordable life saving and live attenuated varicella vaccine Nexipox.
NOVO Medi Sciences Pvt Org Chart
Is NOVO Medi Sciences Pvt your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NOVO Medi Sciences Pvt is spiking on competitors!
Product Launch: Get notified when NOVO Medi Sciences Pvt launches new products
Website visits: Recent activity has been detected on your website
NOVO Medi Sciences Pvt, which may be a good buyer, showed buying intent in Masked Content Topic
Check if NOVO Medi Sciences Pvt has recently received funding, and reach out quickly before it becomes old news!
Click to see if NOVO Medi Sciences Pvt had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at NOVO Medi Sciences Pvt
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NOVO Medi Sciences Pvt recently announced quarterly report
Funding: Get notified immidiatlly once NOVO Medi Sciences Pvt has new funding data
Recommended Actions
Reach out to Masked Content who joined NOVO Medi Sciences Pvt as Masked Content
Find 3 more new buyers
NOVO Medi Sciences Pvt Employee Growth Rate
View NOVO Medi Sciences Pvt’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
NOVO Medi Sciences Pvt Tech Stack
A closer look at the technologies used by NOVO Medi Sciences Pvt
Most Recent Scoops
Frequently Asked Questions Regarding NOVO Medi Sciences Pvt
Novo Medi is an leading Indian Pharmaceutical company in providing affordable life saving and live attenuated varicella vaccine Nexipox.... Read More
